217 related articles for article (PubMed ID: 31263574)
21. Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles?
Campello E; Radu CM; Duner E; Lombardi AM; Spiezia L; Bendo R; Ferrari S; Simioni P; Fabris F
Cytometry B Clin Cytom; 2018 Mar; 94(2):334-341. PubMed ID: 28052584
[TBL] [Abstract][Full Text] [Related]
22. Dynamic antibody-binding properties in the pathogenesis of HIT.
Sachais BS; Litvinov RI; Yarovoi SV; Rauova L; Hinds JL; Rux AH; Arepally GM; Poncz M; Cuker A; Weisel JW; Cines DB
Blood; 2012 Aug; 120(5):1137-42. PubMed ID: 22577175
[TBL] [Abstract][Full Text] [Related]
23. Activation of platelets by sera containing IgG1 heparin-dependent antibodies: an explanation for the predominance of the Fc gammaRIIa "low responder" (his131) gene in patients with heparin-induced thrombocytopenia.
Denomme GA; Warkentin TE; Horsewood P; Sheppard JA; Warner MN; Kelton JG
J Lab Clin Med; 1997 Sep; 130(3):278-84. PubMed ID: 9341987
[TBL] [Abstract][Full Text] [Related]
24. Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT.
Krauel K; Preuße P; Warkentin TE; Trabhardt C; Brandt S; Jensch I; Mandelkow M; Hammer E; Hammerschmidt S; Greinacher A
Blood; 2019 Feb; 133(9):978-989. PubMed ID: 30573633
[TBL] [Abstract][Full Text] [Related]
25. Measurement of procoagulant platelets provides mechanistic insight and diagnostic potential in heparin-induced thrombocytopenia.
Lee CSM; Selvadurai MV; Pasalic L; Yeung J; Konda M; Kershaw GW; Favaloro EJ; Chen VM
J Thromb Haemost; 2022 Apr; 20(4):975-988. PubMed ID: 35038779
[TBL] [Abstract][Full Text] [Related]
26. Prothrombotic factors enhance heparin-induced thrombocytopenia and thrombosis in vivo in a mouse model.
Reilly MP; Taylor SM; Franklin C; Sachais BS; Cines DB; Williams KJ; McKenzie SE
J Thromb Haemost; 2006 Dec; 4(12):2687-94. PubMed ID: 16961586
[TBL] [Abstract][Full Text] [Related]
27. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.
Prechel MM; Jeske WP; Walenga JM
Thromb Res; 2010 Apr; 125(4):e143-8. PubMed ID: 19931120
[TBL] [Abstract][Full Text] [Related]
28. Immune complexes formed following the binding of anti-platelet factor 4 (CXCL4) antibodies to CXCL4 stimulate human neutrophil activation and cell adhesion.
Xiao Z; Visentin GP; Dayananda KM; Neelamegham S
Blood; 2008 Aug; 112(4):1091-100. PubMed ID: 18539895
[TBL] [Abstract][Full Text] [Related]
29. Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia.
Nazy I; Clare R; Staibano P; Warkentin TE; Larché M; Moore JC; Smith JW; Whitlock RP; Kelton JG; Arnold DM
J Thromb Haemost; 2018 Jul; 16(7):1402-1412. PubMed ID: 29723924
[TBL] [Abstract][Full Text] [Related]
30. Platelet-activating anti-PF4 disorders: An overview.
Warkentin TE
Semin Hematol; 2022 Apr; 59(2):59-71. PubMed ID: 35512902
[TBL] [Abstract][Full Text] [Related]
31. Heparin-induced thrombocytopenia: in vitro studies on the interaction of dabigatran, rivaroxaban, and low-sulfated heparin, with platelet factor 4 and anti-PF4/heparin antibodies.
Krauel K; Hackbarth C; Fürll B; Greinacher A
Blood; 2012 Feb; 119(5):1248-55. PubMed ID: 22049520
[TBL] [Abstract][Full Text] [Related]
32. Management of heparin-induced thrombocytopenia.
Warkentin TE; Greinacher A
Curr Opin Hematol; 2016 Sep; 23(5):462-70. PubMed ID: 27380556
[TBL] [Abstract][Full Text] [Related]
33. Heparin-independent, PF4-dependent binding of HIT antibodies to platelets: implications for HIT pathogenesis.
Padmanabhan A; Jones CG; Bougie DW; Curtis BR; McFarland JG; Wang D; Aster RH
Blood; 2015 Jan; 125(1):155-61. PubMed ID: 25342714
[TBL] [Abstract][Full Text] [Related]
34. Role of monocytes and endothelial cells in heparin-induced thrombocytopenia.
Madeeva D; Cines DB; Poncz M; Rauova L
Thromb Haemost; 2016 Oct; 116(5):806-812. PubMed ID: 27487857
[TBL] [Abstract][Full Text] [Related]
35. Off-the-shelf cryopreserved platelets for the detection of HIT and VITT antibodies.
Kanack AJ; Jones CG; Singh B; Leger RR; Splinter NP; Heikal NM; Pruthi RK; Chen D; George G; Abou-Ismail MY; Wool GD; Gundabolu K; Padmanabhan A
Blood; 2022 Dec; 140(25):2722-2729. PubMed ID: 35998675
[TBL] [Abstract][Full Text] [Related]
36. Distinguishing between anti-platelet factor 4/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia.
Nazi I; Arnold DM; Warkentin TE; Smith JW; Staibano P; Kelton JG
J Thromb Haemost; 2015 Oct; 13(10):1900-7. PubMed ID: 26291604
[TBL] [Abstract][Full Text] [Related]
37. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.
Padmanabhan A; Jones CG; Curtis BR; Bougie DW; Sullivan MJ; Peswani N; McFarland JG; Eastwood D; Wang D; Aster RH
Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366
[TBL] [Abstract][Full Text] [Related]
38. Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia.
Amiral J; Wolf M; Fischer A; Boyer-Neumann C; Vissac A; Meyer D
Br J Haematol; 1996 Mar; 92(4):954-9. PubMed ID: 8616093
[TBL] [Abstract][Full Text] [Related]
39. Heparin enhances uptake of platelet factor 4/heparin complexes by monocytes and macrophages.
Joglekar M; Khandelwal S; Cines DB; Poncz M; Rauova L; Arepally GM
J Thromb Haemost; 2015 Aug; 13(8):1416-27. PubMed ID: 25960020
[TBL] [Abstract][Full Text] [Related]
40. Novel diagnostic assays for heparin-induced thrombocytopenia.
Cuker A; Rux AH; Hinds JL; Dela Cruz M; Yarovoi SV; Brown IA; Yang W; Konkle BA; Arepally GM; Watson SP; Cines DB; Sachais BS
Blood; 2013 May; 121(18):3727-32. PubMed ID: 23446735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]